
Academician Xia Qiang leads the medical team of Renji Hospital to carry out transnational medical assistance
Xia Qiang, academician of the Chinese Academy of Engineering, led the medical team of Shanghai Renji Hospital to Uzbekistan and worked with local experts to successfully complete the country's first minimally invasive living donor liver transplantation, saving a 42-year-old Uzbek female patient suffering from acute-on-chronic liver failure.
AI-generated summary
Academician Xia Qiang’s team from Renji Hospital went to Malaysia in 2019 to guide the completion of the country’s first batch of children’s living donor liver transplants.
China News Service, Shanghai, October 13 (Chen Jing, Huang Xing) Reporters learned from Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine (hereinafter referred to as Renji Hospital) on the 13th that Xia Qiang, an academician of the Chinese Academy of Engineering, led a medical team to Uzbekistan to provide medical technical assistance. Chinese and Uzbekian experts worked together to successfully complete Uzbekistan's first minimally invasive living donor liver transplant.
In this cross-border assistance, Xia Qiang's team not only brought advanced minimally invasive liver transplantation surgery technology, but also conveyed a set of mature liver transplantation medical concepts.
Ms. Dilnosha, 42, from Namangan Oblast in eastern Uzbekistan, was diagnosed with acute-on-chronic liver failure at the V. Vakhidov Surgical Medical Center (Vakhidov Center) in Tashkent, the capital of the country. This is a serious life-threatening disease. It is affected by acute triggers on the basis of chronic liver disease and can easily induce multiple organ failure, with a mortality rate as high as 30%-50%.
Experts from the Wahidov Center sought help from the liver surgery team at Renji Hospital in Shanghai, China. The hospital quickly coordinated resources and established a multidisciplinary support team including liver surgery, anesthesiology, and critical care medicine. Under the leadership of Academician Xia Qiang, they traveled thousands of miles to Uzbekistan.
While in Uzbekistan, the Renji Medical Team led by Academician Xia Qiang, together with the Uzbek team led by Professor Seedmurad Ismailov and Professor Fazlidin Bakhritdinov of Wahidov Medical Center, successfully completed the country's first minimally invasive living donor liver transplantation.
According to Renji Hospital, previously adult living donor liver transplant surgeries in Uzbekistan generally used the traditional laparotomy method, which resulted in large postoperative wound areas and long recovery periods. This cross-border cooperation innovatively uses minimally invasive liver transplantation technology, which greatly reduces body trauma and is more conducive to the rapid recovery of the donor after surgery. The surgical incision is strictly controlled within 8 centimeters, ensuring medical safety and surgical efficacy while taking into account the postoperative appearance.
A letter of thanks from the patient’s family to the Chinese doctor. (Photo courtesy of Yanji Hospital)
The donor liver for this transplant came from patient Dilnosha's 19-year-old son Sadobek. Currently, Dilnosha's vital signs are stable after surgery, and various indicators are recovering well. Her family specially asked Dr. Wufang to send a Chinese letter of thanks to the Renji Hospital team, praising the Renji experts for their superb medical skills and bringing hope and strength to the family.
"Living donor liver transplantation involves both the donor and the recipient. We must not only do our best to treat patients with end-stage liver disease, but also put the safety of healthy donors in a prominent position." Academician Xia Qiang said that in this overseas technical assistance, the team has always regarded donor protection, rigorous preoperative evaluation, and multidisciplinary integrated collaboration as the core concepts of assistance.
It is reported that this is not the first time that a liver transplant program from China has benefited overseas patients. In 2019, Professor Xia Qiang's team went to Kuala Lumpur, Malaysia, to guide the country's experts in completing the first two children's living donor liver transplants in the country's history. "This time, we not only hope to complete an operation with the local team, but also look forward to bringing the team's mature diagnosis and treatment concepts to the Belt and Road countries." Academician Xia Qiang pointed out.
During the visit, Renji Hospital and Wahidov Medical Center signed a memorandum of cooperation. The two medical institutions will steadily promote multi-dimensional cooperation in the future, including carrying out special training for medical personnel, organizing joint discussions on difficult transplant cases, deepening experience exchanges on perioperative management and long-term follow-up, and exploring scientific research collaboration in children's liver transplantation, donor safety protection, and long-term prognosis of transplantation.

The Centers for Disease Control and Prevention pointed out that last week, the number of deaths from influenza in a single week reached 46, a new high this year. It is expected that the epidemic period will be out of the epidemic in mid-to-late November; the new coronavirus pneumonia will be out of the epidemic as early as next week. Officials call on high-risk groups to get vaccinated as soon as possible to reduce the risk of severe illness and death.

Recently, "Those who like to use laundry beads are in trouble" has become a hot search topic. Some netizens used their hands to tear the beads away from moisture, causing detergent to splash into their eyes, causing corneal corrosion. Experts analyzed the high-concentration components and strong corrosion of laundry beads, and gave safety guidelines on first aid for eye splashes, prevention of accidental ingestion, and avoidance of mixing detergents.

Xi Jinping delivered an important speech at the National Hygiene and Health Conference, emphasizing the need to unswervingly follow the path of health and wellness development with Chinese characteristics to ensure decisive progress in building a healthy China during the "15th Five-Year Plan" period. He pointed out that people's health is an important symbol of national prosperity and country strength. Health and health undertakings play an overall and fundamental role, and the health-first development strategy must be firmly implemented. Li Qiang made a concluding speech, and Zhao Leji, Wang Huning, Cai Qi, Ding Xuexiang and Li Xi attended the meeting.

A British research team found through a mouse bone marrow model that intestinal inflammation changes the bone marrow environment, leading to an increase in HMGB2 molecules, which in turn reactivates dormant breast cancer cells and increases the risk of metastatic tumor growth. However, they emphasize that inflammation does not mean that cancer will definitely recur.

The Hsinchu County Government cooperates with the Ministry of Health and Welfare to increase the subsidy program for residential service users, increasing the subsidy amount from a maximum of 120,000 yuan per person per year to a maximum of 15,000 yuan per month. The annual subsidy ceiling reaches 180,000 yuan, and applications can be applied retroactively to New Year's Day this year. The subsidy targets are expanded to those with proof of long-term care disability level 4 or above or with physical or mental disabilities above moderate, and the exclusionary regulations for the rich are cancelled. Applications are divided into two phases, the first phase ends on October 30, and the second phase ends on December 16.

Director Hong Zhaohong of Kaohsiung Chang Gung Memorial Hospital pointed out that early liver cancer often has no obvious symptoms, and more than 40% of patients in Taiwan are in the middle and late stages when diagnosed. With the development of targeted drugs, immunotherapy and local therapies, some patients with intermediate and advanced stage tumors have shrunk after treatment, and they can re-evaluate eradication treatment opportunities through "Conversion curative therapy", such as ablation, surgery or liver transplantation. He reminded patients with hepatitis B, hepatitis C, chronic hepatitis and cirrhosis to follow up regularly according to risks to avoid delaying treatment opportunities.